Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01922245 · ClinicalTrials.gov registry record · NA

tDCS and Aphasia Treatment

A NA study, sponsored by Hunter College of City University of New York.

Completed
Registry status
NA
Development phase
1
Enrollment target

NCT01922245: Completed NA study, sponsored by Hunter College of City University of New York.

NCT01922245 is a NA study that has completed, run by Hunter College of City University of New York. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01922245, a NA study, has completed, sponsored by Hunter College of City University of New York.

COMPLETED
Registry status
NA
Development phase
1 participants
Enrollment target

Study Summary

This project will investigate the use of noninvasive brain stimulation in the form of tDCS (transcranial direct current stimulation) in conjunction with speech-language therapy, for the improvement of language production in stroke survivors with aphasia. The hypothesis is that anodal tDCS and speech-language therapy will facilitate improved outcomes compared to speech therapy alone.

Primary Outcome

Naming will be tested using standardized tests such at the Boston Naming Test and or the Philadelphia Naming Test. In addition, sentence probes have been created that will assess naming in the sentence context throughout the study.

Interventions

  • DEVICE Soterix 1x1 tDCS

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2013-07
Est. Completion 2016-01
Phase NA

What the finished NCT01922245 record still lists

NCT01922245 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Soterix 1x1 tDCS is the first listed.

NCT01922245 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01922245 about?

NCT01922245 is a clinical study titled "tDCS and Aphasia Treatment". This project will investigate the use of noninvasive brain stimulation in the form of tDCS (transcranial direct current stimulation) in conjunction with speech-language therapy, for the improvement of language production in stroke survivors with aphasia. The hypothesis is that anodal tDCS and speech...

What is the current status of trial NCT01922245?

This trial is currently completed. It is a NA study. The enrollment target is 1 participants. The study started on 2013-07. Estimated completion is 2016-01.

What interventions are being tested in trial NCT01922245?

The interventions under investigation include: Soterix 1x1 tDCS (DEVICE).

Who is sponsoring clinical trial NCT01922245?

This trial is sponsored by Hunter College of City University of New York, which has 29 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01922245's enrollment target sits among peer trials

1 2001st of 2000 the lowest of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01922245, the US trial registry maintained by the National Library of Medicine. NCT01922245 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.